Fidelity Investments
STLN

Fidelity Investments’s Starling Oncology STLN Stock Holding History

Fidelity Investments’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
78,107
+28,576
+58% +$120K ﹤0.01% 3353
2026
Q1 		$152K Buy
49,531
+48,039
+3,220% +$147K ﹤0.01% 3621
2025
Q4 		$5.31K Buy
1,492
+866
+138% +$3.21K ﹤0.01% 4881
2025
Q3 		$2.19K Buy
626
+107
+21% +$367 ﹤0.01% 4923
2025
Q2 		$1.06K Buy
+519
New +$1.3K ﹤0.01% 4957
2024
Q4 		– Sell
-4,749,900
Closed -$1.55M – 5810
2024
Q3 		$1.55M Sell
4,749,900
-1,489
-0% -$617 ﹤0.01% 2471
2024
Q2 		$2.19M Sell
4,751,389
-2,159
-0% -$1.84K ﹤0.01% 2326
2024
Q1 		$7.51M Sell
4,753,548
-535
-0% -$1.02K ﹤0.01% 1960
2023
Q4 		$9.7M Sell
4,754,083
-100
-0% -$173 ﹤0.01% 1855
2023
Q3 		$6.66M Buy
4,754,183
+100
+0% +$103 ﹤0.01% 1955
2023
Q2 		$2.62M Sell
4,754,083
-7,245,917
-60% -$3.83M ﹤0.01% 2258
2023
Q1 		$8.13M Sell
12,000,000
-1,982
-0% -$2.53K ﹤0.01% 1953
2022
Q4 		$19.8M Buy
12,001,982
+1,713
+0% +$4.81K ﹤0.01% 1616
2022
Q3 		$55.6M Buy
12,000,269
+191
+0% +$1.12K 0.01% 1208
2022
Q2 		$60.7M Buy
12,000,078
+78
+0% +$568 0.01% 1177
2022
Q1 		$85.6M Hold
12,000,000
– – 0.01% 1135
2021
Q4 		$111M Buy
+12,000,000
New +$107M 0.01% 1057

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments's STLN Position: Q2 2026 in Review

Fidelity Investments increased its Starling Oncology (STLN) stake by 58% in Q2 2026, buying an estimated $120K and bringing the position to 78,107 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #3353.

Fidelity Investments first reported a position in STLN in Q4 2021 and has held it in 17 quarters since. The position peaked at $111M in Q4 2021. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Fidelity Investments held 78,107 shares of Starling Oncology worth $424K as of Q2 2026.
  • Fidelity Investments bought 28,576 Starling Oncology shares in Q2 2026, an estimated $120K.
  • Starling Oncology made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3353 holding.
  • Fidelity Investments first reported a position in Starling Oncology in Q4 2021 and has held it in 17 quarters since.
  • Fidelity Investments's Starling Oncology position peaked at $111M in Q4 2021.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.